CELEX: 62018CA0387
Language: en
Date: 2019-07-03 00:00:00
Title: Case C-387/18: Judgment of the Court (Fifth Chamber) of 3 July 2019 (request for a preliminary ruling from the Wojewódzki Sąd Administracyjny w Warszawie — Poland) — Delfarma sp. z o.o. v Prezes Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych (Reference for a preliminary ruling — Articles 34 and 36 TFEU — Free movement of goods — Measure having equivalent effect to a quantitative restriction — Protection of health and life of humans — Parallel import of medicinal products — Reference medicinal products and generic medicinal products — Requirement that the imported medicinal product and that which has been granted a marketing authorisation in the Member State of importation are both reference medicinal products or are both generic medicinal products)

9.9.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 305/23
            
         
      Judgment of the Court (Fifth Chamber) of 3 July 2019 (request for a preliminary ruling from the Wojewódzki Sąd Administracyjny w Warszawie — Poland) — Delfarma sp. z o.o. v Prezes Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych
      (Case C-387/18) (1)
      
      (Reference for a preliminary ruling - Articles 34 and 36 TFEU - Free movement of goods - Measure having equivalent effect to a quantitative restriction - Protection of health and life of humans - Parallel import of medicinal products - Reference medicinal products and generic medicinal products - Requirement that the imported medicinal product and that which has been granted a marketing authorisation in the Member State of importation are both reference medicinal products or are both generic medicinal products)
      (2019/C 305/28)
      Language of the case: Polish
      
         Referring court
      
      Wojewódzki Sąd Administracyjny w Warszawie
      
         Parties to the main proceedings
      
      
         Applicant: Delfarma sp. z o.o.
      
         Defendant: Prezes Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych
      
         Operative part of the judgment
      
      Articles 34 and 36 TFEU must be interpreted as precluding the legislation of a Member State, such as that at issue in the main proceedings, which requires, for the issue of a parallel import licence for a medicinal product, that that medicinal product and the medicinal product which has been granted a marketing authorisation in that Member State are both reference medicinal products or both generic medicinal products and which, therefore, prohibits the issue of any parallel import licence for a medicinal product where it is a generic medicinal product whereas the medicinal product previously authorised in that Member State is a reference medicinal product.
      
         (1)  OJ C 294, 20.8.2018.